Jens Vikse

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

The Semmelweis Framework: structuring evidence foundations and expert opinion in clinical practice guidelines.

The Semmelweis Framework: structuring evidence foundations and expert opinion in clinical practice guidelines.

Journal: BMC medical research methodology

Published: April 27, 2026

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Journal: European journal of internal medicine

Published: December 15, 2025

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply.

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease. Author's reply.

Journal: European journal of internal medicine

Published: December 05, 2025

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG).

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG).

Journal: Annals of the rheumatic diseases

Published: September 05, 2025

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Journal: European journal of internal medicine

Published: July 03, 2025

Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease.

Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease.

Journal: United European gastroenterology journal

Published: December 31, 2024

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease.

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease.

Journal: The European respiratory journal

Published: December 23, 2024

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort.

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort.

Journal: Arthritis research & therapy

Published: July 12, 2023

Rheumatology congresses post COVID-19: we cannot regress.

Rheumatology congresses post COVID-19: we cannot regress.

Journal: The Lancet. Rheumatology

Published: June 26, 2023

Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs.

Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs.

Journal: Acta bio-medica : Atenei Parmensis

Published: August 27, 2021

Outcomes of extracorporeal life support for respiratory failure in children with primary immunodeficiencies.

Outcomes of extracorporeal life support for respiratory failure in children with primary immunodeficiencies.

Journal: Perfusion

Published: July 19, 2021

Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.

Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.

Journal: Journal of medical virology

Published: January 28, 2021

Showing 1-12 of 66

Last Updated: 09/26/2026